开云app官网登录入口网页版-官方正版

#肿瘤免疫微环境#

16篇内容 | 1706人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2163210, encodeId=ddba216321066, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a><a href='/topic/show?id=493ae869206' target=_blank style='color:#2F92EE;'>#结直肠癌#</a><a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a><a href='/topic/show?id=c8ee32526f3' target=_blank style='color:#2F92EE;'>#前列腺癌#</a><a href='/topic/show?id=f0838291817' target=_blank style='color:#2F92EE;'>#肿瘤微环境#</a><a href='/topic/show?id=912810e037ee' target=_blank style='color:#2F92EE;'>#瘤内神经#</a><a href='/topic/show?id=8a5110e03807' target=_blank style='color:#2F92EE;'>#神经重编程#</a>，这篇综述十分有价值。以前都关注<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>，但是对瘤内神经的重视程度是不够的，但是肿瘤的神经浸润是常见的，但是它的作用并不清楚! 这个综述全面将瘤内神经的作用全面概括，也许未来为相关的治疗的研发也有价值。, objectTitle=CDD综述：靶向肿瘤神经支配：前提、承诺和挑战, objectType=article, longId=796493, objectId=d188e9649368, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301016/1697486271652_4754896.webp, objectUrl=/article/show_article.do?id=d188e9649368, replyNumber=1, likeNumber=143, createdTime=2023-10-17, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d188e9649368, moduleTitle=CDD综述：靶向肿瘤神经支配：前提、承诺和挑战, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d188e9649368)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=2212745, encodeId=bb502212e4567, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a> <a href='/topic/show?id=116d11615e8a' target=_blank style='color:#2F92EE;'>#Ceralasertib#</a> <a href='/topic/show?id=c70b11615830' target=_blank style='color:#2F92EE;'>#免疫耐药#</a>, objectTitle=读书报告 | ATR抑制剂Ceralasertib通过调节肿瘤免疫微环境逆转免疫耐药, objectType=article, longId=832359, objectId=9266832359e7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719547525074_8538692.png, objectUrl=/article/show_article.do?id=9266832359e7, replyNumber=0, likeNumber=41, createdTime=2024-07-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=9266832359e7, moduleTitle=读书报告 | ATR抑制剂Ceralasertib通过调节肿瘤免疫微环境逆转免疫耐药, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=9266832359e7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2197327, encodeId=a5b2219e327c6, content=<a href='/topic/show?id=daf52906537' target=_blank style='color:#2F92EE;'>#免疫治疗#</a> <a href='/topic/show?id=cbcce745264' target=_blank style='color:#2F92EE;'>#纳米药物#</a> <a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=施剑林院士团队最新JACS展望：纳米药物重塑肿瘤微环境用于实体瘤免疫治疗, objectType=article, longId=820523, objectId=f63182052395, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-team-discussing-together-in-the-hallway-PJWSSDB.jpg, objectUrl=/article/show_article.do?id=f63182052395, replyNumber=0, likeNumber=119, createdTime=2024-04-07, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=f63182052395, moduleTitle=施剑林院士团队最新JACS展望：纳米药物重塑肿瘤微环境用于实体瘤免疫治疗, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f63182052395)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2174935, encodeId=772821e4935ab, content=<a href='/topic/show?id=c8ee32526f3' target=_blank style='color:#2F92EE;'>#前列腺癌#</a> <a href='/topic/show?id=f9033e2331d' target=_blank style='color:#2F92EE;'>#去势抵抗性#</a> <a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=【综述】| 去势抵抗性前列腺癌免疫微环境的研究现状与治疗方向, objectType=article, longId=804839, objectId=b4488048393f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696894120696_4754896.jpeg, objectUrl=/article/show_article.do?id=b4488048393f, replyNumber=0, likeNumber=84, createdTime=2023-12-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b4488048393f, moduleTitle=【综述】| 去势抵抗性前列腺癌免疫微环境的研究现状与治疗方向, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b4488048393f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2174416, encodeId=43ab21e4416a7, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a> <a href='/topic/show?id=f98710851339' target=_blank style='color:#2F92EE;'>#RAS/MAPK信号通路#</a>, objectTitle=大咖谈 | RAS/RAF/MEK通路突变及干预策略, objectType=article, longId=804630, objectId=b56c804630aa, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-writing-D3K6QME.jpg, objectUrl=/article/show_article.do?id=b56c804630aa, replyNumber=0, likeNumber=121, createdTime=2023-12-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b56c804630aa, moduleTitle=大咖谈 | RAS/RAF/MEK通路突变及干预策略, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=b56c804630aa)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2121878, encodeId=2fba21218e86c, content=<a href='/topic/show?id=0d7e9559e44' target=_blank style='color:#2F92EE;'>#酸性微环境#</a><a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=如何理解肿瘤免疫微环境的异质性？, objectType=article, longId=751226, objectId=3ef7e5122677, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668019382192_4754896.png, objectUrl=/article/show_article.do?id=3ef7e5122677, replyNumber=0, likeNumber=106, createdTime=2023-03-26, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3ef7e5122677, moduleTitle=如何理解肿瘤免疫微环境的异质性？, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3ef7e5122677)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2116725, encodeId=ce472116e256c, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a><a href='/topic/show?id=029e2901e8e' target=_blank style='color:#2F92EE;'>#免疫微环境#</a>, objectTitle=肿瘤免疫微环境中免疫细胞的“两面性”, objectType=article, longId=752555, objectId=6b58e52555ce, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221121/1669011847053_5295905.jpg, objectUrl=/article/show_article.do?id=6b58e52555ce, replyNumber=0, likeNumber=102, createdTime=2023-02-27, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6b58e52555ce, moduleTitle=肿瘤免疫微环境中免疫细胞的“两面性”, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=6b58e52555ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1428724, encodeId=d2831428e246d, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=【Nat Med】肿瘤免疫微环境在大B细胞淋巴瘤CAR T治疗中具有决定性作用, objectType=article, longId=738108, objectId=602be38108fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=602be38108fe, replyNumber=0, likeNumber=111, createdTime=2022-09-07, rootId=0, userName=风铃822, userId=f1b54130162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=602be38108fe, moduleTitle=【Nat Med】肿瘤免疫微环境在大B细胞淋巴瘤CAR T治疗中具有决定性作用, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=602be38108fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1428723, encodeId=2ecb1428e23f5, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=肿瘤免疫微环境的异质性, objectType=article, longId=734896, objectId=da77e34896d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da77e34896d5, replyNumber=0, likeNumber=109, createdTime=2022-08-07, rootId=0, userName=风铃822, userId=f1b54130162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da77e34896d5, moduleTitle=肿瘤免疫微环境的异质性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=da77e34896d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1428722, encodeId=bb931428e2291, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=Liver Cancer：肿瘤免疫微环境可揭示哪些肝癌患者可从抗PD-1治疗中获益！, objectType=article, longId=216223, objectId=1ec121622392, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ec121622392, replyNumber=0, likeNumber=95, createdTime=2021-08-25, rootId=0, userName=风铃822, userId=f1b54130162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ec121622392, moduleTitle=Liver Cancer：肿瘤免疫微环境可揭示哪些肝癌患者可从抗PD-1治疗中获益！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=1ec121622392)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1428721, encodeId=73be1428e21e4, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=Nat Commun：CNS肿瘤免疫微环境分析揭示抗肿瘤免疫相关性, objectType=article, longId=200495, objectId=17e9200495fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17e9200495fd, replyNumber=0, likeNumber=166, createdTime=2020-09-11, rootId=0, userName=风铃822, userId=f1b54130162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17e9200495fd, moduleTitle=Nat Commun：CNS肿瘤免疫微环境分析揭示抗肿瘤免疫相关性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=17e9200495fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1428720, encodeId=ed091428e20fa, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=Clin Cancer Res：小剂量二甲双胍对食管癌肿瘤免疫微环境的影响, objectType=article, longId=199170, objectId=37351991e0b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37351991e0b8, replyNumber=0, likeNumber=129, createdTime=2020-08-12, rootId=0, userName=风铃822, userId=f1b54130162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37351991e0b8, moduleTitle=Clin Cancer Res：小剂量二甲双胍对食管癌肿瘤免疫微环境的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=37351991e0b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1428719, encodeId=1a6e1428e19ad, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=Brit J Cancer：抗PD-L1免疫治疗和放疗联用对肿瘤免疫微环境的影响 , objectType=article, longId=197412, objectId=512719e41250, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=512719e41250, replyNumber=0, likeNumber=97, createdTime=2020-07-14, rootId=0, userName=风铃822, userId=f1b54130162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=512719e41250, moduleTitle=Brit J Cancer：抗PD-L1免疫治疗和放疗联用对肿瘤免疫微环境的影响 , moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=512719e41250)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1428718, encodeId=837e1428e18ed, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=Cancer Immunol Immunother：肿瘤免疫微环境对白细胞增多症患者的影响, objectType=article, longId=194785, objectId=fa5a194e85a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa5a194e85a8, replyNumber=0, likeNumber=98, createdTime=2020-05-28, rootId=0, userName=风铃822, userId=f1b54130162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa5a194e85a8, moduleTitle=Cancer Immunol Immunother：肿瘤免疫微环境对白细胞增多症患者的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=fa5a194e85a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1428717, encodeId=5dcd1428e1706, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=J Hepatol：单区域样本评估肝细胞癌中肿瘤免疫微环境的可靠性, objectType=article, longId=194769, objectId=c752194e69d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c752194e69d2, replyNumber=0, likeNumber=86, createdTime=2020-05-28, rootId=0, userName=风铃822, userId=f1b54130162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c752194e69d2, moduleTitle=J Hepatol：单区域样本评估肝细胞癌中肿瘤免疫微环境的可靠性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c752194e69d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1428716, encodeId=040b1428e160e, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=CD73在肿瘤免疫微环境中的研究进展, objectType=article, longId=159535, objectId=3f95159535c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f95159535c5, replyNumber=0, likeNumber=100, createdTime=2019-02-07, rootId=0, userName=风铃822, userId=f1b54130162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f95159535c5, moduleTitle=CD73在肿瘤免疫微环境中的研究进展, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3f95159535c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1428715, encodeId=2add1428e150d, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=Ann Oncol：肿瘤浸润IL17阳性细胞激活胃癌抗肿瘤免疫微环境和促进辅助化疗反应性, objectType=article, longId=155388, objectId=e768155388ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e768155388ab, replyNumber=0, likeNumber=123, createdTime=2018-12-10, rootId=0, userName=风铃822, userId=f1b54130162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e768155388ab, moduleTitle=Ann Oncol：肿瘤浸润IL17阳性细胞激活胃癌抗肿瘤免疫微环境和促进辅助化疗反应性, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=e768155388ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1428714, encodeId=0a101428e1442, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=Sci Rep：NSCLC检查点抑制剂疗效的肿瘤免疫微环境综合分析, objectType=article, longId=150476, objectId=dd151504e66a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd151504e66a, replyNumber=0, likeNumber=86, createdTime=2018-10-08, rootId=0, userName=风铃822, userId=f1b54130162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd151504e66a, moduleTitle=Sci Rep：NSCLC检查点抑制剂疗效的肿瘤免疫微环境综合分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=dd151504e66a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1428713, encodeId=0f8b1428e1352, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=冷肿瘤和热肿瘤：肿瘤免疫微环境与免疫治疗, objectType=article, longId=147067, objectId=3e8b14e0671d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e8b14e0671d, replyNumber=0, likeNumber=160, createdTime=2018-08-22, rootId=0, userName=风铃822, userId=f1b54130162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e8b14e0671d, moduleTitle=冷肿瘤和热肿瘤：肿瘤免疫微环境与免疫治疗, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=3e8b14e0671d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1428712, encodeId=466c1428e12ee, content=<a href='/topic/show?id=026382811f6' target=_blank style='color:#2F92EE;'>#肿瘤免疫微环境#</a>, objectTitle=Oncotarget：肿瘤免疫微环境因子竟然与食管鳞状细胞癌患者生存情况有关！, objectType=article, longId=110665, objectId=39f2110665c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39f2110665c1, replyNumber=0, likeNumber=85, createdTime=2017-08-25, rootId=0, userName=风铃822, userId=f1b54130162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39f2110665c1, moduleTitle=Oncotarget：肿瘤免疫微环境因子竟然与食管鳞状细胞癌患者生存情况有关！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=39f2110665c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

肿瘤免疫微环境

2020-05-29发表于威斯康星

侠胆医心 (审核中...)

前往app查看评论内容

全文收起 #肿瘤##结直肠癌##胰腺癌##前列腺癌##肿瘤微环境##瘤内神经##神经重编程#，这篇综述十分有价值。以前都关注#肿瘤免疫微环境#，但是对瘤内神经的重视程度是不够的，但是肿瘤的神经浸润是常见的，但是它的作用并不清楚! 这个综述全面将瘤内神经的作用全面概括，也许未来为相关的治疗的研发也有价值。

CDD综述：靶向肿瘤神经支配：前提、承诺和挑战

2023-10-17发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肿瘤免疫微环境# #Ceralasertib# #免疫耐药#

读书报告 | ATR抑制剂Ceralasertib通过调节肿瘤免疫微环境逆转免疫耐药

2024-07-02发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#免疫治疗# #纳米药物# #肿瘤免疫微环境#

施剑林院士团队最新JACS展望：纳米药物重塑肿瘤微环境用于实体瘤免疫治疗

2024-04-07发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#前列腺癌# #去势抵抗性# #肿瘤免疫微环境#

【综述】| 去势抵抗性前列腺癌免疫微环境的研究现状与治疗方向

2023-12-14发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肿瘤免疫微环境# #RAS/MAPK信号通路#

大咖谈 | RAS/RAF/MEK通路突变及干预策略

2023-12-12发表于上海

侠胆医心 (审核中...)

前往app查看评论内容

#酸性微环境##肿瘤免疫微环境#

如何理解肿瘤免疫微环境的异质性？

2023-03-26发表于上海

showtest (审核中...)

前往app查看评论内容

#肿瘤免疫微环境##免疫微环境#

肿瘤免疫微环境中免疫细胞的“两面性”

2023-02-27发表于上海

风铃822 (审核中...)

前往app查看评论内容

#肿瘤免疫微环境#

【Nat Med】肿瘤免疫微环境在大B细胞淋巴瘤CAR T治疗中具有决定性作用

2022-09-07

风铃822 (审核中...)

前往app查看评论内容

#肿瘤免疫微环境#

肿瘤免疫微环境的异质性

2022-08-07

风铃822 (审核中...)

前往app查看评论内容

#肿瘤免疫微环境#

Liver Cancer：肿瘤免疫微环境可揭示哪些肝癌患者可从抗PD-1治疗中获益！

2021-08-25

风铃822 (审核中...)

前往app查看评论内容

#肿瘤免疫微环境#

Nat Commun：CNS肿瘤免疫微环境分析揭示抗肿瘤免疫相关性

2020-09-11

风铃822 (审核中...)

前往app查看评论内容

#肿瘤免疫微环境#

Clin Cancer Res：小剂量二甲双胍对食管癌肿瘤免疫微环境的影响

2020-08-12

风铃822 (审核中...)

前往app查看评论内容

#肿瘤免疫微环境#

Brit J Cancer：抗PD-L1免疫治疗和放疗联用对肿瘤免疫微环境的影响

2020-07-14

风铃822 (审核中...)

前往app查看评论内容

#肿瘤免疫微环境#

Cancer Immunol Immunother：肿瘤免疫微环境对白细胞增多症患者的影响

2020-05-28

风铃822 (审核中...)

前往app查看评论内容

#肿瘤免疫微环境#

J Hepatol：单区域样本评估肝细胞癌中肿瘤免疫微环境的可靠性

2020-05-28

风铃822 (审核中...)

前往app查看评论内容

#肿瘤免疫微环境#

CD73在肿瘤免疫微环境中的研究进展

2019-02-07

风铃822 (审核中...)

前往app查看评论内容

#肿瘤免疫微环境#

Ann Oncol：肿瘤浸润IL17阳性细胞激活胃癌抗肿瘤免疫微环境和促进辅助化疗反应性

2018-12-10

风铃822 (审核中...)

前往app查看评论内容

#肿瘤免疫微环境#

Sci Rep：NSCLC检查点抑制剂疗效的肿瘤免疫微环境综合分析

2018-10-08

风铃822 (审核中...)

前往app查看评论内容

#肿瘤免疫微环境#

冷肿瘤和热肿瘤：肿瘤免疫微环境与免疫治疗

2018-08-22

风铃822 (审核中...)

前往app查看评论内容

#肿瘤免疫微环境#

Oncotarget：肿瘤免疫微环境因子竟然与食管鳞状细胞癌患者生存情况有关！

2017-08-25

科室
- - 订阅+
  - 更多科室
工具
服务